SECURITIES & EXCHANGE COMMISSION EDGAR FILING CEL SCI CORP. Form: SC 13G/A. Date Filed:

Similar documents
KINGSTONE COMPANIES, INC.

ShotSpotter, Inc. (Name of Issuer)

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. Support.com, Inc. Form: SC 13G/A. Date Filed:

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Rosehill Resources Inc. (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934

PURE BIOSCIENCE, INC. Filed by OKUNO DALE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. KLR Energy Acquisition Corp.

EATON CORP PLC Filed by WELLINGTON MANAGEMENT CO LLP

Main Street Capital Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

LEGACY RESERVES LP Filed by BROTHERS PRODUCTION COMPANY, INC.

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

Inventergy Global, Inc (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. REVOLUTION LIGHTING TECHNOLOGIES (Name of Issuer)

UNITED THERAPEUTICS CORP Filed by SHUMWAY CAPITAL PARTNERS LLC

Spark Therapeutics, Inc.

OAKTREE CAPITAL GROUP, LLC Filed by JMB CAPITAL PARTNERS MASTER FUND L.P.

Realogy Holdings Corp.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Algodon Wines & Luxury Development Group, Inc.

SECURITIES & EXCHANGE COMMISSION EDGAR FILING. HCI Group, Inc. Form: SC 13G/A. Date Filed:

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

Common Stock, par value $0.01 per share (Title of Class of Securities)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

LEGACY RESERVES LP Filed by MORIAH PROPERTIES, LTD.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Signet Jewelers (Name of Issuer)

American Midstream Partners, LP (Name of Issuer)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (Rule 13d-102)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934*

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Ecology & Environment, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Limbach Holdings, Inc (Name of Issuer)

NELNET INC Filed by CEDAR HILL CAPITAL PARTNERS, LLC

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G T100 (CUSIP Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment 2)*

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A Amendment No. 3. Under the Securities Exchange Act of 1934

MOODYS CORP /DE/ Filed by CHILDRENS INVESTMENT FUND MANAGEMENT (UK) LLP

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G (RULE 13d - 102)

united StateS SeCuritieS and exchange COMMiSSiOn Washington, D.C SCHeDuLe 13g

THERAVANCE INC Filed by BAUPOST GROUP LLC/MA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

Limbach Holdings, Inc. (Name of Issuer)

Everi Holdings Inc. (Name of Issuer)

Recro Pharma, Inc. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

ACCESS INTEGRATED TECHNOLOGIES INC

SECURITIES AND EXCHANGE COMMISSION SCHEDULE 13G/A

MEDICAL TRANSCRIPTION BILLING, CORP Filed by OMNI MEDICAL BILLING SERVICES, LLC

SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934

GROUPON, INC. Filed by KEYWELL BRADLEY A

Propetro Holding Corp. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Alliqua BioMedical, Inc.

AON PLC Filed by CAPITAL RESEARCH & MANAGEMENT CO

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C SCHEDULE 13G/A Under the Securities Exchange Act of 1934 (Amendment No.

VERISIGN INC/CA Filed by LONE PINE CAPITAL LLC

CENTERPOINT ENERGY INC Filed by VANGUARD GROUP INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

American Midstream Partners, LP (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, DC SCHEDULE 13G (Rule 13d-102)

ST JOE CO Filed by THIRD AVENUE MANAGEMENT LLC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

PRINCIPAL FINANCIAL GROUP INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

SECURITIES AND EXCHANGE COMMISSION. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

Silvercrest Asset Management Group Inc. (Name of Issuer)

ZYNGA INC Filed by CAPITAL RESEARCH GLOBAL INVESTORS

BARRETT BUSINESS SERVICES, INC. (Name of Issuer) Common Stock (Title of Class of Securities) (CUSIP Number)

Securities and Exchange Commission. Washington, D.C Schedule 13G. Under the Securities Exchange Act of (Amendment No.

Floor & Décor Holdings, Inc. (Name of Issuer)

LEAR CORP Filed by MERRILL LYNCH PIERCE FENNER & SMITH INC

Canada Goose Holdings Inc. (Name of Issuer)

Taubman Centers, Inc. (Name of Issuer)

KAYNE ANDERSON MIDSTREAM ENERGY FUND, INC. (Name of Issuer)

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

Deutsche Bank AG Taunusanlage 12, D Frankfurt am Main Federal Republic of Germany. Jeffrey A. Ruiz Vice President Telephone: (212)

Videocon d2h Limited (Name of Issuer)

Section 1: SC 13G/A (SC 13G/A)

ROCKWELL COLLINS INC Filed by VANGUARD GROUP INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

<SEQUENCE>1 <FILENAME>cpst_sc13g.txt. SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

Vascular Biogenics Ltd.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G/A. Under the Securities Exchange Act of 1934 (Amendment No.

SUNOPTA INC. Filed by GRUBER & MCBAINE CAPITAL MANAGEMENT LLC

BRIDGEPOINT EDUCATION, INC. (Name of Issuer)

3M CO Filed by BLACKROCK INC.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C Schedule 13G. Under the Securities Exchange Act of 1934 (Amendment No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of (Amendment No.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC SCHEDULE 13G (Rule 13d-102)

WASTE MANAGEMENT INC Filed by VANGUARD GROUP INC

SECURITIES AND EXCHANGE COMMISSION Washington, D.C SCHEDULE 13G. Under the Securities Exchange Act of 1934 (Amendment No.

COMCAST CORP Filed by MICROSOFT CORP

Transcription:

SECURITIES & EXCHANGE COMMISSION EDGAR FILING CEL SCI CORP Form: SC 13G/A Date Filed: 2019-02-13 Corporate Issuer CIK: 725363 Copyright 2019, Issuer Direct Corporation. All Right Reserved. Distribution of this document is strictly prohibited, subject to the terms of use.

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Amendment No. 4 INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 CEL-SCI CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 150837408 (CUSIP Number) December 31, 2018 (Date of Event Which Requires Filing of This Statement) Check the Appropriate box to designate the rule pursuant to which this schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d)

CUSIP No. 150837408 13G Page 2 of 6 of Pages 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS MMCAP International Inc. SPC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands 5 SOLE VOTING POWER NUMBER OF 0 SHARES 6 SHARED VOTING POWER BENEFICIALLY 1,584,894* OWNED BY 7 SOLE DISPOSITIVE POWER EACH 0 REPORTING 8 SHARED DISPOSITIVE POWER PERSON WITH 1,584,894* 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,584,894* 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 Up to 9.99%** 12 TYPE OF REPORTING PERSON* CO *SEE INSTRUCTIONS BEFORE FILLING OUT!

CUSIP No. 150837408 13G Page 3 of 6 of Pages 1 NAME OF REPORTING PERSONS S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS MM Asset Management Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Ontario, Canada 5 SOLE VOTING POWER NUMBER OF 0 SHARES 6 SHARED VOTING POWER BENEFICIALLY 1,584,894* OWNED BY 7 SOLE DISPOSITIVE POWER EACH 0 REPORTING 8 SHARED DISPOSITIVE POWER PERSON WITH 1,584,894* 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,584,894* 10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 Up to 9.99%** 12 TYPE OF REPORTING PERSON* CO *SEE INSTRUCTIONS BEFORE FILLING OUT!

CUSIP No. 150837408 13G Page 4 of 6 of Pages Item 1 (a). Name of Issuer: Cel-Sci Corporation Item 1(b). Address of Issuer s Principal Executive Offices: 8229 Boone Boulevard, Suite 802 Vienna, Virginia 22182 Item 2 (a). Name of Person Filing: i) MMCAP International Inc. SPC ii) MM Asset Management Inc. Item 2 (b). Address of Principal Business Office or, if None, Residence: i) P. O. Box 259 George Town Financial Centre 90 Fort Street Grand Cayman, Cayman Islands KY1-1208 ii) 66 Wellington Street West, Suite 2707 Toronto, Ontario M5K 1H6 Canada Item 2 (c). Citizenship: i) Cayman Islands ii) Ontario, Canada Item 2 (d). Title of Class of Securities: Common Stock Item 2 (e). CUSIP Number: 150837408 Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: (a) Broker or dealer registered under Section 15 of the Act; (b) (c) (d) (e) (f) (g) (h) Bank as defined in Section 3(a)(6) of the Act; Insurance Company as defined in Section 3(a)(19) of the Act; Investment Company registered under Section 8 of the Investment Company Act; Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); Employee benefit plan or endowment plan in accordance with Rule 13d-1(b)(1)(ii)(F); Parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G); A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940: (j) Group, in accordance with Rule 13d-1(b)(1)(ii)(j). If this statement is filed pursuant to Rule 13d-1(c), check this box.

CUSIP No. 150837408 13G Page 5 of 6 of Pages Item 4. Ownership. Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1. (a) Amount beneficially owned: 1,584,894* (b) Percent of class: Up to 9.99%** (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: 0 (ii) Shared power to vote or to direct the vote: 1,584,894* (iii) Sole power to dispose or to direct the disposition of: 0 (iv) Shared power to dispose or to direct the disposition of: 1,584,894* *Includes Series V warrants convertible into 101,264 common shares of the Issuer; Series W warrants convertible into 119,403 common shares of the Issuer; Series CC warrants convertible into 160,000 common shares of the Issuer; Series DD warrants convertible into 320,000 common shares of the Issuer; Series EE warrants convertible into 320,000 common shares of the Issuer; Series SS warrants convertible into 163,158 common shares of the Issuer; and Series TT warrants convertible into 401,069 common shares of the Issuer. **The percentages used herein are calculated based upon 28,388,453 outstanding shares of the Issuer as of December 11, 2018, plus 1,584,894 common shares in aggregate underlying warrants which are beneficially owned by the reporting persons and included pursuant to Rule 13d-3(d)(1)(i) of the Securities Exchange Act of 1934, as amended. The Series CC, Series DD, and Series EE warrants are not exercisable if, as a result of an exercise, the holder would then become a ten percent beneficial owner of the Issuer s common stock, as defined in Rule 16a-2 under the Securities Exchange Act of 1934, as amended (the Act ). The Series SS and Series TT warrants are not exercisable if the holder would beneficially own over 4.99% of the Issuer's common stock after exercise. Instruction. For computations regarding securities which represent a right to acquire an underlying security, see Rule 13d-3(d)(1). Item 5. Ownership of Five Percent or Less of a Class. If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More than Five Percent on Behalf of Another Person. N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. N/A Item 8. Identification and Classification of Members of the Group. N/A Item 9. Notice of Dissolution of Group. N/A

CUSIP No. 150837408 13G Page 6 of 6 of Pages Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 13, 2019 (Date) MMCAP International Inc. SPC By: /s/ Matthew MacIsaac Matthew MacIsaac, Director February 13, 2019 (Date) MM Asset Management Inc. By: /s/ Hillel Meltz Hillel Meltz, President